Page 32 - Boxed Warning News Today

Omisirge is an umbilical cord blood-based therapy that may prevent infection in patients with blood cancer undergoing stem cell transplant.

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based...

The FDA has updated the prescribing information for all opioid analgesics in order to provide additional guidance on how to safely prescribe these medications.

Increased mortality risk consistent with other antipsychotics in elderly dementia patients

Detailed price information for Aurinia Pharm Ord (AUPH-Q) from The Globe and Mail including charting and trades.

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that two scientific abstracts on the clinical...

ImmunoGen to Receive $75 Million Upon Execution of the Agreement; Eligible to Receive up to an Additional $100 Million in Near-Term Proceeds ... | April 6, 2023

(BPT) - The story you are about to read may not be representative of all people living with schizophrenia. The opinions expressed here are those of Robert, a person living

Lumateperone 42mg was statistically significant on the primary endpoint of symptom reduction on the Montgomery Asberg Depression Rating Scale for each patient population including: -combined major... | March 28, 2023

The FDA has approved Lunsumio (mosunetuzumab-axgb) to treat adults with R/R follicular lymphoma after 2 or more lines of systemic therapy.